Experienced Health Care Team

Experienced Team with Strong Relationships and Networks

 

James A. Breckenridge, Partner 

James A. BreckenridgeMr. Breckenridge co-founded Med Opportunity Partners, LLC, an operating oriented private equity firm focused on the health care sector, in 2006.  From 1993 to 2006, Mr. Breckenridge was a partner at UBS Capital Americas, LLC, a private equity firm with $1.0 billion of committed capital and affiliated with UBS AG, and leader of its health care investing efforts.  Mr. Breckenridge joined UBS Capital Americas upon its formation in 1993. Since 1997, Mr. Breckenridge led UBS Capital Americas’ investment efforts in the healthcare and life science sectors. Mr. Breckenridge has originated, executed and led $85 million of investments in bio-pharmaceutical, pharmaceutical, and medical device / medical technology related investments. Including non-healthcare investments, Mr. Breckenridge has overseen and participated in private equity transactions aggregating over $2 billion in total value since 1993 and equity investments of $195 million. Mr. Breckenridge led the acquisition of Pfanstiehl, Inc. in 2013 and led UBS Capital Americas’ majority recapitalization investment in Avail Medical Products, Inc.  Mr. Breckenridge earned a MBA from Columbia University and a BA from Colgate University. Mr. Breckenridge serves as Chairman and Chief Executive Officer of Pfanstiehl, Inc.

Vicente Trelles, Operating Partner 

Vicente TrellesMr. Trelles co-founded Med Opportunity Partners, LLC. From April 2011 to May 2013, Mr. Trelles was Executive Vice President, Worldwide Operations, Shared Services and R&D at Orthofix International, N.V.  Orthofix is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets. From 2001 to March 2006 he was Executive Vice President and COO of Inamed Corporation. Mr. Trelles was a senior member of INAMED’s management team that created over $2.8 billion of shareholder value in four years. During that period Inamed’s sales increased from $240 million to $430 million and earnings doubled. As Executive Vice President and Chief Operations Officer, Mr. Trelles was responsible for managing INAMED’s global operations including product development, regulatory compliance, and key strategic business partnerships. He currently serves as a director of the board of Revance Therapeutics Inc., a pre-IPO biotechnology company focused on targeted therapeutics and delivery systems, Vibrynt Corp. a medical device start up company focused on obesity and Reliable Biopharmaceutical Corporation. Mr. Trelles has spent over 24 years within the medical device and pharmaceutical industries managing global operations at INAMED, Allergan and Baxter Healthcare. From 1999-2001, he was the Chief Operating Officer of McGhan Medical (a wholly owned subsidiary of INAMED) From 1990-1999, Mr. Trelles was a senior operating executive at Allergan, Inc. including, VP Worldwide Surgical Operations, Vice President Europe Operations, Vice President of Manufacturing for their Contact Lens Business and General Manager of the Contact Lens Division in Puerto Rico. From 1981-1990, Mr. Trelles held management positions of increasing responsibilities at Baxter Health Care Corporation and American Hospital Supply including General Manager of its V. Mueller Division in Puerto Rico. Mr. Trelles received a BS in Industrial Engineering from the University of Puerto Rico.